Search results for "emics"

showing 10 items of 867 documents

Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

2021

During almost all 2020, coronavirus disease 2019 (COVID-19) pandemic has constituted the major risk for the worldwide health and economy, propelling unprecedented efforts to discover drugs for its prevention and cure. At the end of the year, these efforts have culminated with the approval of vaccines by the American Food and Drug Administration (FDA) and the European Medicines Agency (EMA) giving new hope for the future. On the other hand, clinical data underscore the urgent need for effective drugs to treat COVID-19 patients. In this work, we embarked on a virtual screening campaign against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Mpro chymotrypsin-like cysteine pro…

Coronavirus disease 2019 (COVID-19)General Chemical Engineeringmedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)In silicoComputational biologyLibrary and Information Sciences01 natural sciencesMolecular Docking SimulationAntiviral AgentsArticleDocking (dog)0103 physical sciencesmedicineHumansProtease InhibitorsPandemicsVirtual screeningProtease010304 chemical physicsbusiness.industrySARS-CoV-2COVID-19General Chemistry0104 chemical sciencesComputer Science ApplicationsMolecular Docking Simulation010404 medicinal & biomolecular chemistryTarget proteinbusinessJournal of Chemical Information and Modeling
researchProduct

Europe’s War against COVID-19: A Map of Countries’ Disease Vulnerability Using Mortality Indicators

2020

Specific and older age-associated comorbidities increase mortality risk in severe forms of coronavirus disease (COVID-19). We matched COVID-19 comorbidities with causes of death in 28 EU countries for the total population and for the population above 65 years and applied a machine-learning-based tree clustering algorithm on shares of death for COVID-19 comorbidities and for influenza and on their growth rates between 2011 and 2016. We distributed EU countries in clusters and drew a map of the EU populations&rsquo

Coronavirus disease 2019 (COVID-19)Health Toxicology and Mutagenesis030231 tropical medicinePopulationPneumonia ViralVulnerabilityeastern countrieslcsh:MedicineTotal populationDiseasecomorbiditiesArticle03 medical and health sciencesBetacoronavirus0302 clinical medicinePandemicHumans030212 general & internal medicineeducationwestern countriesPandemicsHealth policyAgedDisease vulnerabilityeducation.field_of_studySARS-CoV-2lcsh:RPublic Health Environmental and Occupational HealthCOVID-19mortalityCoronavirusEuropeGeographyCoronavirus InfectionsDemographyInternational Journal of Environmental Research and Public Health
researchProduct

Covid-19 Pandemic: What Changes for Dentists and Oral Medicine Experts? A Narrative Review and Novel Approaches to Infection Containment

2020

The authors performed a narrative review on Severe Acute Respiratory Syndrome- CoronaVirus-2 ( SARS-CoV-2) and all infectious agents with the primary endpoints to illustrate the most accepted models of safety protocols in dentistry and oral medicine, and to propose an easy view of the problem and a comparison (pre- vs post-COVID19) for the most common dental procedures. The outcome is forecast to help dentists to individuate for a given procedure the differences in terms of safety protocols to avoid infectious contagion (by SARS-CoV-2 and others dangerous agents). An investigation was performed on the online databases Pubmed and Scopus using a combination of free words and Medical Subject H…

Coronavirus disease 2019 (COVID-19)Health Toxicology and MutagenesisPneumonia ViralScopusoral medicinelcsh:MedicineReviewRisk AssessmentBetacoronavirus03 medical and health sciences0302 clinical medicineRisk FactorsPandemicmedicineHumans030212 general & internal medicinePandemicsPersonal Protective EquipmentPersonal protective equipmentCross InfectionInfection ControldentistrySARS-CoV-2business.industrylcsh:RPublic Health Environmental and Occupational HealthCOVID-19Subject (documents)030206 dentistrymedicine.diseasepersonal protective equipment (PPE)Narrative reviewMedical emergencyCoronavirus InfectionsRisk assessmentbusinessOral medicineInternational Journal of Environmental Research and Public Health
researchProduct

Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals

2021

Worldwide, the COVID-19 pandemic has caused a decline in blood donations, between 30% and 70% in some of the most affected countries. In Spain, during the initial eight weeks after the State of Emergency was decreed on 14 March 2020, in the weekly reports of the Health Ministry, an average decrease of 20% was observed between 11 and week 25 compared with the 2018 donation. We aimed to investigate the impact of the COVID-19 pandemic on blood donations and blood distribution in four autonomous communities, and to explore the evolution of the consumption of blood components (BCs) in ten hospitals of six autonomous communities. We performed a prospective study of grouped cohorts on the donation…

Coronavirus disease 2019 (COVID-19)MedicinaHealth Toxicology and Mutagenesislcsh:MedicineBlood Donors030230 surgeryArticle03 medical and health sciencesBlood donations0302 clinical medicinePandemicHumansMedicineProspective Studies030212 general & internal medicineProspective cohort studyPandemicsRetrospective StudiestransfusionConsumption (economics)SARS-CoV-2business.industrypandemiclcsh:RPublic Health Environmental and Occupational HealthCOVID-19Retrospective cohort studyHospitalsSpainDonationPacked red blood cellsbusinessDemographyInternational Journal of Environmental Research and Public Health
researchProduct

The patient-doctor relationship: new insights in light of the current Ministerial recommendations regarding Phase 2 of the COVID-19 pandemic

2020

Following the publication of the italian Ministerial recommendations relating to dentistry in Phase 2 of the coViD-19 pandemic (focusing on operational protocols for all dental staff), we believe that the patient/dentist relationship should increasingly take into account the heightened fears and anxious thoughts of patients. this particularly regards patients who are about to undergo dental work. Moreover, dentists should also pay close attention to recent events, which have determined the new recommendations regarding SarS-coV-2 biocontainment. Furthermore, the authors of this paper consider it appropriate to make suggestions and develop interventionist techniques regarding the interface w…

Coronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEPhase (combat)Dentist-Patient RelationsBetacoronavirus03 medical and health sciences0302 clinical medicineDental StaffPandemicHumansDental CarePandemicsDentist-Patient RelationsMedical educationSARS-CoV-2COVID-19italian Ministerial recommendations Phase 2 covid-19 dentistry protocols030206 dentistryBiocontainmentItalyOtorhinolaryngologyWork (electrical)SurgeryOral SurgeryCoronavirus InfectionsPsychology030217 neurology & neurosurgeryMinerva Stomatologica
researchProduct

Chloroquine for COVID-19: rationale, facts, hopes

2020

The tragedy of the pandemic coronavirus disease 2019 (COVID-19) led to a desperate search for effective treatments. Chloroquine (CQ), an aminoquinoline used for many years for the prophylaxis and therapy of malaria and autoimmune diseases, has been put forward as a treatment option. The fact that CQ is not patented and has been in clinical use for years is a major advantage. CQ has been shown to have antiviral effects in SARS, MERS, Ebola, and HIV infections, but without data showing clinical effectiveness [1, 2]. Does the current level of evidence suffice for prescribing CQ for COVID-19?

Coronavirus disease 2019 (COVID-19)Treatment outcomeCoronaviruPneumonia ViralMEDLINECritical Care and Intensive Care Medicinemedicine.disease_causeAntiviral AgentsAntimalarialsBetacoronavirusChloroquinePandemicmedicineHumansPandemicsCoronavirusClinical Trials as Topicbiologybusiness.industrySARS-CoV-2lcsh:Medical emergencies. Critical care. Intensive care. First aidCOVID-19Chloroquinelcsh:RC86-88.9Pneumoniabiology.organism_classificationmedicine.diseaseVirologyCOVID-19 Drug TreatmentCoronavirusPneumoniaTreatment OutcomeEditorialbusinessCoronavirus InfectionsCOVID-19 ; Chloroquine ; Pneumonia ; SARS-CoV-2 ; CoronavirusBetacoronavirusmedicine.drug
researchProduct

Why is COVID-19 especially impacting the African American population?

2020

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, penetrates human cells through direct binding with ...

Coronavirus disease 2019 (COVID-19)virusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia Viral030204 cardiovascular system & hematologymedicine.disease_causeepidemicsVirus03 medical and health sciences0302 clinical medicinePandemicmedicineHumans030212 general & internal medicinePandemicsCoronavirusoutbreakCoronavirus COVID-19 outbreak epidemicsViral Epidemiologybusiness.industryCOVID-19virus diseasesOutbreakHealth Status DisparitiesGeneral Medicinemedicine.diseaseVirologyUnited StatesBlack or African AmericanCoronavirusPneumoniaEditorialCoronavirus InfectionsbusinessAnnals of Medicine
researchProduct

COVID 19 vaccine in the pediatric age: the recommendation of the Italian Pediatric Society

2022

AbstractVaccine is an important and effective tool to protect from preventable infectious diseases. Neverthless, in the COVID-19 pandemic era, scientific and accurate information are required to responde to false and misleading information on efficacy and safety of immunization in the pediatric age.

Covid-19 vaccineVaccinesCOVID-19 VaccinesPandemicVaccinationHesitancyCOVID-19HumansChildren Covid-19 vaccine HesitancyChildChildrenPandemicsHumanItalian Journal of Pediatrics
researchProduct

Variation in communication and family visiting policies in intensive care within and between countries during the Covid-19 pandemic: The COVISIT inte…

2022

Background: During the COVID-19 pandemic, intensive care units (ICU) introduced restrictions to in-person family visiting to safeguard patients, healthcare personnel, and visitors. Methods: We conducted a web-based survey (March– July 2021) investigating ICU visiting practices before the pandemic, at peak COVID-19 ICU admissions, and at the time of survey response. We sought data on visiting pol icies and communication modes including use of virtual visiting (videoconferencing). Results: We obtained 667 valid responses representing ICUs in all continents. Before the pandemic, 20% (106/ 525) had unrestricted visiting hours ; 6% (30/525) did not allow in-person visiting. At peak, 84% (558/667…

Critical CareCommunicationCOVID-19Visitors to PatientsCritical Care and Intensive Care MedicineOrganizational PolicyIntensive Care UnitsPolicyIntensive careRestrictionHumansFamilyPandemicsvisiting restriction intensive careVisiting
researchProduct

There is a relationship between obesity and COVID‐19 but more information is needed

2020

Abstract We read with particular interest your comments in Obesity regarding the Coronavirus‐19 (COVID‐19) epidemic (1) and a related manuscript by Simonnet et al. (2). Resolution of the specific relationship between obesity and COVID‐19, two existing public health epidemics, is critically needed to potentially prevent health systems worldwide from being overburdened. Few studies describing COVID‐19 with rates of obesity exist, and most are based on heterogeneous populations (Table 1) (2‐7). In cohort studies with COVID‐19 disease, obesity rates are generally reported as no higher than population‐based estimates; in contrast, subgroups of critically ill patients (e.g, intensive care unit (I…

Critical CareSARS-CoV-2Pneumonia ViralCOVID-19Social SupportComorbiditySeverity of Illness Indexobesity COVID-19 incidence prevalenceUnited StatesBetacoronavirusSocial IsolationRisk FactorsHumansObesitySettore MED/49 - Scienze Tecniche Dietetiche ApplicateLetters to the EditorCoronavirus InfectionsLetter to the EditorPandemicsObesity (Silver Spring, Md.)
researchProduct